Clinical

Dataset Information

0

Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis


ABSTRACT: The Bev-IP trial is designed to assess the feasibility and efficacy of a combined treatment consisting of perioperative combination chemotherapy with the vascular endothelial growth factor A inhibitor bevacizumab and cytoreductive surgery with intraperitoneal oxaliplatin.

DISEASE(S): Carcinoma,Colorectal Neoplasms

PROVIDER: 2186592 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| PRJNA604833 | ENA
| 2084383 | ecrin-mdr-crc
| 2636593 | ecrin-mdr-crc
| 2172835 | ecrin-mdr-crc
| 2531315 | ecrin-mdr-crc
2018-03-03 | GSE111351 | GEO
| 2214131 | ecrin-mdr-crc
2023-11-30 | PXD047390 | iProX
2021-08-10 | GSE165798 | GEO
| 2120911 | ecrin-mdr-crc